Abstract
In order to determine on which chromosome the gene controlling human cytochrome P-450 (debrisoquine/sparteine type) is located a linkage study of polymorphic sparteine oxidation (PSO) to various polymorphic markers was carried out. Positive information for linkage between PSO and the P1 blood group was obtained with a maximal LOD-score of LOD = 3.35 for both male and female recombination fraction estimates of theta m = theta f = 0.0. The P1 blood group has been recently mapped to the long arm of chromosome 22. Thus it can be concluded that the gene controlling human cytochrome P-450 (debrisoquine/sparteine) is situated on the long arm of chromosome 22 in close vicinity to P1.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ayesh R., Idle J. R., Ritchie J. C., Crothers M. J., Hetzel M. R. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature. 1984 Nov 8;312(5990):169–170. doi: 10.1038/312169a0. [DOI] [PubMed] [Google Scholar]
- Barbeau A., Cloutier T., Roy M., Plasse L., Paris S., Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet. 1985 Nov 30;2(8466):1213–1216. doi: 10.1016/s0140-6736(85)90743-3. [DOI] [PubMed] [Google Scholar]
- Carroll M. C., Belt K. T., Palsdottir A., Yu Y. Molecular genetics of the fourth component of human complement and steroid 21-hydroxylase. Immunol Rev. 1985 Oct;87:39–60. doi: 10.1111/j.1600-065x.1985.tb01144.x. [DOI] [PubMed] [Google Scholar]
- Eichelbaum M., Bertilsson L., Säwe J., Zekorn C. Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities. Clin Pharmacol Ther. 1982 Feb;31(2):184–186. doi: 10.1038/clpt.1982.29. [DOI] [PubMed] [Google Scholar]
- Eichelbaum M., Mineshita S., Ohnhaus E. E., Zekorn C. The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmacol. 1986 Jul;22(1):49–53. doi: 10.1111/j.1365-2125.1986.tb02879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eichelbaum M., Reetz K. P., Schmidt E. K., Zekorn C. The genetic polymorphism of sparteine metabolism. Xenobiotica. 1986 May;16(5):465–481. doi: 10.3109/00498258609050252. [DOI] [PubMed] [Google Scholar]
- Guengerich F. P., Distlerath L. M., Reilly P. E., Wolff T., Shimada T., Umbenhauer D. R., Martin M. V. Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation. Xenobiotica. 1986 May;16(5):367–378. doi: 10.3109/00498258609050245. [DOI] [PubMed] [Google Scholar]
- Hildebrand C. E., Gonzalez F. J., McBride O. W., Nebert D. W. Assignment of the human 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15. Nucleic Acids Res. 1985 Mar 25;13(6):2009–2016. doi: 10.1093/nar/13.6.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leemann T., Dayer P., Meyer U. A. Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers. Eur J Clin Pharmacol. 1986;29(6):739–741. doi: 10.1007/BF00615971. [DOI] [PubMed] [Google Scholar]
- Meyer U. A., Gut J., Kronbach T., Skoda C., Meier U. T., Catin T., Dayer P. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica. 1986 May;16(5):449–464. doi: 10.3109/00498258609050251. [DOI] [PubMed] [Google Scholar]
- Phillips I. R., Shephard E. A., Povey S., Davis M. B., Kelsey G., Monteiro M., West L. F., Cowell J. A cytochrome P-450 gene family mapped to human chromosome 19. Ann Hum Genet. 1985 Oct;49(Pt 4):267–274. doi: 10.1111/j.1469-1809.1985.tb01702.x. [DOI] [PubMed] [Google Scholar]
- Tippett P., Kaplan J. C. Report of the Committee on the Genetic Constitution of Chromosomes 20, 21, and 22. Cytogenet Cell Genet. 1985;40(1-4):268–295. doi: 10.1159/000132177. [DOI] [PubMed] [Google Scholar]